remedy labs research group ltd
remedy labs research group ltd Company Information
Company Number
11065848
Next Accounts
Aug 2025
Shareholders
stephen spaulding hickok
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
+1Registered Address
7 battersea square, london, SW11 3RA
Website
remedyresearch.orgremedy labs research group ltd Estimated Valuation
Pomanda estimates the enterprise value of REMEDY LABS RESEARCH GROUP LTD at £342 based on a Turnover of £366 and 0.94x industry multiple (adjusted for size and gross margin).
remedy labs research group ltd Estimated Valuation
Pomanda estimates the enterprise value of REMEDY LABS RESEARCH GROUP LTD at £0 based on an EBITDA of £0 and a 4.04x industry multiple (adjusted for size and gross margin).
remedy labs research group ltd Estimated Valuation
Pomanda estimates the enterprise value of REMEDY LABS RESEARCH GROUP LTD at £185 based on Net Assets of £100 and 1.86x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Remedy Labs Research Group Ltd Overview
Remedy Labs Research Group Ltd is a live company located in london, SW11 3RA with a Companies House number of 11065848. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in November 2017, it's largest shareholder is stephen spaulding hickok with a 100% stake. Remedy Labs Research Group Ltd is a young, micro sized company, Pomanda has estimated its turnover at £366.2 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Remedy Labs Research Group Ltd Health Check
Pomanda's financial health check has awarded Remedy Labs Research Group Ltd a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 6 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
6 Weak
Size
annual sales of £366.2, make it smaller than the average company (£3.8m)
- Remedy Labs Research Group Ltd
£3.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (9%)
- Remedy Labs Research Group Ltd
9% - Industry AVG
Production
with a gross margin of 25.7%, this company has a higher cost of product (49.7%)
- Remedy Labs Research Group Ltd
49.7% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Remedy Labs Research Group Ltd
- - Industry AVG
Employees
with 1 employees, this is below the industry average (45)
- Remedy Labs Research Group Ltd
45 - Industry AVG
Pay Structure
on an average salary of £69.2k, the company has an equivalent pay structure (£69.2k)
- Remedy Labs Research Group Ltd
£69.2k - Industry AVG
Efficiency
resulting in sales per employee of £366.2, this is less efficient (£122k)
- Remedy Labs Research Group Ltd
£122k - Industry AVG
Debtor Days
it gets paid by customers after 99 days, this is later than average (54 days)
- Remedy Labs Research Group Ltd
54 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Remedy Labs Research Group Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Remedy Labs Research Group Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Remedy Labs Research Group Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Remedy Labs Research Group Ltd
- - Industry AVG
REMEDY LABS RESEARCH GROUP LTD financials
Remedy Labs Research Group Ltd's latest turnover from November 2023 is estimated at £366 and the company has net assets of £100. According to their latest financial statements, we estimate that Remedy Labs Research Group Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | ||||||
| Intangible Assets | ||||||
| Investments & Other | ||||||
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | ||||||
| Stock & work in progress | ||||||
| Trade Debtors | 100 | 100 | 100 | 100 | 100 | |
| Group Debtors | ||||||
| Misc Debtors | ||||||
| Cash | ||||||
| misc current assets | ||||||
| total current assets | 100 | 100 | 100 | 100 | 100 | |
| total assets | 100 | 100 | 100 | 100 | 100 | |
| Bank overdraft | ||||||
| Bank loan | ||||||
| Trade Creditors | ||||||
| Group/Directors Accounts | ||||||
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | ||||||
| total current liabilities | ||||||
| loans | ||||||
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | ||||||
| total long term liabilities | ||||||
| total liabilities | ||||||
| net assets | 100 | 100 | 100 | 100 | 100 | |
| total shareholders funds | 100 | 100 | 100 | 100 | 100 |
| Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | ||||||
| Amortisation | ||||||
| Tax | ||||||
| Stock | ||||||
| Debtors | 100 | |||||
| Creditors | ||||||
| Accruals and Deferred Income | ||||||
| Deferred Taxes & Provisions | ||||||
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | ||||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | ||||||
| Other Short Term Loans | ||||||
| Long term loans | ||||||
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | ||||||
| overdraft | ||||||
| change in cash |
remedy labs research group ltd Credit Report and Business Information
Remedy Labs Research Group Ltd Competitor Analysis
Perform a competitor analysis for remedy labs research group ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SW11 area or any other competitors across 12 key performance metrics.
remedy labs research group ltd Ownership
REMEDY LABS RESEARCH GROUP LTD group structure
Remedy Labs Research Group Ltd has no subsidiary companies.
Ultimate parent company
REMEDY LABS RESEARCH GROUP LTD
11065848
remedy labs research group ltd directors
Remedy Labs Research Group Ltd currently has 2 directors. The longest serving directors include Mr Stephen Hickok (Nov 2017) and Mr Jason Sender (Jan 2025).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Stephen Hickok | United Kingdom | 80 years | Nov 2017 | - | Director |
| Mr Jason Sender | England | 49 years | Jan 2025 | - | Director |
P&L
November 2023turnover
366.2
-5%
operating profit
0
0%
gross margin
25.7%
-8.22%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
100
0%
total assets
100
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
remedy labs research group ltd company details
company number
11065848
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology
incorporation date
November 2017
age
8
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
November 2023
previous names
remedy research labs limited (June 2024)
accountant
POWER HYNES ASSOCIATES
auditor
-
address
7 battersea square, london, SW11 3RA
Bank
-
Legal Advisor
-
remedy labs research group ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to remedy labs research group ltd.
remedy labs research group ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for REMEDY LABS RESEARCH GROUP LTD. This can take several minutes, an email will notify you when this has completed.
remedy labs research group ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
